DEXAMETHASONE

Spinal Cord Injury

Kessler FoundationSmall moleculePhase 2Dormant

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 95/ 100

Competitive context

19 Active assets in the Spinal Cord Injury cohort.

Asset / Sponsor	Phase	Rating
Pregabalin Ju Seok Ryu	Phase 4	BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- MetroHealth Medical Center	Phase 4	BB
Semaglutide James J. Peters Veterans Affairs Medical Center	Phase 4	BB
VENLOR University of Washington	Phase 4	BB
Brivaracetam University of Minnesota	Phase 3	BB

View all 42 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant

A

Indicative ·

82 / 100

adult acute lymphoblastic leukemiaDormant

BBB

Indicative ·

79 / 100

B-cell childhood acute lymphoblastic leukemiaDormant

BBB

Indicative ·

78 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.